Immutep Ltd Sustainability Reports
Immutep Limited is a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases. The company is a pioneer in therapeutics related to the Lymphocyte Activation Gene-3 (LAG-3) protein.
Sector: Professional & technical services
Country: Australia
Exchange: Australian Securities Exchange
LEI: 529900OL6C5CY5P8BH38
FIGI: BBG001S6M829
17 reports from 2011 to 2026
